<DOC>
	<DOCNO>NCT02267980</DOCNO>
	<brief_summary>The investigator evaluate effect subanesthetic dose ketamine , administer adjunct sevoflurane , duration seizure activity , hemodynamic profile recovery time electroconvulsive therapy ( ECT ) patient major depression .</brief_summary>
	<brief_title>Effect Addition Ketamine Sevoflurane Anesthesia Electroconvulsive Therapy</brief_title>
	<detailed_description>Patients randomly allocate , either sevoflurane-ketamine ( Group SK ) , sevoflurane-saline ( Group SS ) receive group . Mean arterial pressure ( MAP ) heart rate ( HR ) record prior anesthetic induction ( T1 ) ; follow anesthetic induction ( T2 ) ; 0 , 1 , 3 , 10 min seizure end ( T3 , T4 , T5 , T6 , respectively ) . Motor EEG seizure duration record .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Major depressive patient Pregnancy Have history myocardial infarction previous six month Atrial fibrillation flutter Heart block Unregulated hypertension Cerebrovascular diseases A know drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Electroconvulsive therapy ; sevoflurane ; ketamine</keyword>
</DOC>